Contacter le RP
Pour utiliser cette fonctionnalité, vous devez bénéficier d'un compte Babbler.
Babbler permet aux journalistes et communicants de collaborer plus simplement.
En vous connectant, vous pourrez accéder gratuitement aux espaces presse des centaines d'entreprises de vos secteurs qui sont sur Babbler, entrer en contact direct avec leurs équipes RP mais aussi y partager vos prochains sujets !
Leurs espaces presse sont sur Babbler :
Vous êtes à 1 clic de l'inscription !
Content de vous revoir !
Antimicrobial Susceptibility Testing Market - Size, Share, Outlook and Current Trends
minutes de lecture
minute de lecture
The global antimicrobial susceptibility testing market size was valued at US$ 2.65 billion in 2017 and is expected to witness a CAGR of 6.2% over the forecast period (2018 – 2026).
Resistance among various microbial species to different antimicrobial drugs have emerged as a major cause of public health threat. According to World Health Organization (WHO), these resistant microorganisms such as bacteria, fungi, viruses, and parasites are able to combat attack by antimicrobial drugs, which leads to ineffective treatment resulting in persistence and spreading of infections.
Increasing number of multidrug resistance cases in tuberculosis (TB), malaria, HIV, influenza, and others among the global population is expected to result in increasing adoption of antimicrobial susceptibility testing to reduce the resistance exposure during the forecast period. For instance, according to the WHO, in 2016, an estimated 490,000 people worldwide developed MDR-TB. The countries with the largest numbers of MDR/RR-TB cases were China, India and the Russian Federation. Moreover, development of genotypic-based methods offering rapid and accurate detection or confirmation of antimicrobial resistance is expected to drive the market growth. For instance, the Accelerate ID/AST System or ID/AST System (Accelerate) aims to reduce the turnaround time by using genetic methods. The device can identify infectious pathogens in a matter of hours instead of days, reducing diagnostic time by 30 to 50 hours.
Get HOLISTIC Request Sample Copy Of This Business Report:
Antimicrobial Susceptibility Testing Market Restraints
Stringent government regulations is the major restraining factor for the antimicrobial susceptibility testing market growth. Regulatory procedures creates barrier to AST development, as clinical validation and trials are lengthy and often too costly for small-sized or medium-sized enterprises or organizations.
For instance, in the U.S., a manufacturer who intends to market a device of generic type must conform to the general controls of Section 513(a)(1)(B) of the Federal Food, Drug and Cosmetic Act, address the risks to health associated with the AST system, and obtain a substantial equivalence assessment from the FDA.
Antimicrobial Susceptibility Testing Market - Regional Insights
On the basis of region, the global antimicrobial susceptibility testing market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be the most lucrative region in the antimicrobial susceptibility testing market in 2017 due to the emergence of a multidrug resistant strain of Salmonella in the U.S. For instance, according to the Centers for Disease Control and Prevention (CDC), September 2018, around two million people are infected with antibiotic-resistant bacteria in the U.S. annually and around 23,000 people die as a result. Moreover, government agencies in the U.S. have taken steps to prevent and control antibiotic resistance, which is expected to increase the adoption of antimicrobial susceptibility testing in the country.
Asia Pacific antimicrobial susceptibility testing market revenue is expected to foresee significant growth over the forecast period due to high prevalence of microbial infections and increasing consumption of antibiotics, eventually developing resistance among the population. According to a WHO report, in 2014, multidrug-resistant tuberculosis rates were high in India and treatment for the disease is generally limited.
Click To Reading More On Antimicrobial Susceptibility Testing Market
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
- Health & Medicine
Autres actualités de la marque
Félicitations, vous êtes inscrit sur BABBLER !
Pour découvrir dès maintenant toutes les actualités qui vous attendent sur Babbler, consultez votre newsfeed !
Vos domaines ont été préselectionnés. Vous pouvez les compléter en cliquant ici
- Health & Medicine